Surgepays Stock Target Price and Analyst Consensus
SURG Stock | USD 3.69 0.05 1.37% |
The current analyst and expert consensus on Surgepays is Buy, with only one strong buy opinion. The current projected Surgepays target price consensus is 13.00 with 2 analyst opinions. The most common way Surgepays analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Surgepays executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Surgepays. We encourage you to use your own analysis of Surgepays to validate this buy or sell advice. Surgepays buy-or-sell recommendation module provides average expert sentiment on the projected Surgepays target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Surgepays to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.
Lowest Forecast 11.83 | Highest Forecast 14.43 | Target Price 13 |
Surgepays |
It's important to approach Surgepays' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Surgepays Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgepays target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Surgepays' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
2 | Buy |
Most Surgepays analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Surgepays stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Surgepays, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSurgepays Target Price Projection
Surgepays' current and average target prices are 3.69 and 13.00, respectively. The current price of Surgepays is the price at which Surgepays is currently trading. On the other hand, Surgepays' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Surgepays Target Price
Surgepays Analyst Ratings
Surgepays' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Surgepays stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Surgepays' financials, market performance, and future outlook by experienced professionals. Surgepays' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Surgepays price targets
Surgepays' stock target price is an estimate of its future price, usually made by analysts. Using Surgepays' target price to determine if it is a suitable investment can be done through the following steps:- Look at Surgepays' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Surgepays' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Surgepays Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Surgepays is a key component of Surgepays valuation and have some predictive power on the future returns of a Surgepays.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Surgepays' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Adviser Favorites Invested few shares | ||
ESG Investing Invested few shares | ||
Blockchain Invested few shares | ||
Warren Buffett Holdings Invested few shares | ||
Driverless Cars Invested over 200 shares | ||
FinTech Invested over 70 shares | ||
Banking Invested over 30 shares | ||
Automobiles and Trucks Invested over 200 shares | ||
Macroaxis Index Invested over 90 shares | ||
Check out Macroaxis Advice on Surgepays to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
The data published in Surgepays' official financial statements usually reflect Surgepays' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Surgepays. For example, before you start analyzing numbers published by Surgepays accountants, it's critical to develop an understanding of what Surgepays' liquidity, profitability, and earnings quality are in the context of the Wireless Telecommunication Services space in which it operates.
Please note, the presentation of Surgepays' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Surgepays' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Surgepays' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgepays. Please utilize our Beneish M Score to check the likelihood of Surgepays' management manipulating its earnings.